Net Cash Provided by (Used in) Operating Activities |
3.87M |
USD |
+152% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-1.46M |
USD |
+98.4% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
11.6M |
USD |
|
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
10M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
8.64M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
14M |
USD |
|
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
77M |
USD |
+10.3% |
Q2 2024 |
Q2 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
1.54M |
USD |
-75.9% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Gross |
2.07M |
USD |
-51.5% |
Q4 2023 |
FY 2023 |
Depreciation |
2.99M |
USD |
-1.45% |
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Deferred Federal Income Tax Expense (Benefit) |
-1.07M |
USD |
-106% |
Q2 2024 |
Q2 2024 |
Additional Paid in Capital |
261M |
USD |
+0.35% |
Q2 2024 |
Q2 2024 |
Current Federal Tax Expense (Benefit) |
2.8M |
USD |
-96.4% |
Q2 2024 |
Q2 2024 |
Depreciation, Depletion and Amortization |
3.19M |
USD |
-15.2% |
Q1 2024 |
Q1 2024 |